首页 > 市场调查报告书 > 医疗设备

动物模型市场规模、份额和成长分析（按动物类型、技术、应用、最终用户和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1896108

动物模型市场规模、份额和成长分析（按动物类型、技术、应用、最终用户和地区划分）—产业预测（2026-2033 年）

Animal Model Market Size, Share, and Growth Analysis, By Animal Type (Mice, Rat), By Technology (CRISPR, Microinjection), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球动物模型市场规模预计在 2024 年达到 30.3 亿美元，从 2025 年的 32.8 亿美元成长到 2033 年的 61.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.1%。

全球动物模型市场是研究人员的重要资源，提供他们能够精确模拟人类生理和病理的模型。慢性疾病（包括癌症、心血管疾病和神经系统疾病）发生率的上升是推动市场扩张的关键因素。特别是，基因改造动物（例如基因转殖小鼠）技术的进步，使得研究人员能够更深入地探索特定基因与疾病进展之间的关係。此外，对个人化医疗的日益重视也推动了对患者来源动物模型的需求，从而促进了个人化治疗方案的发展。儘管面临伦理困境和新替代方案的出现等挑战，动物模型市场在疾病认知和药物研发中仍然发挥着至关重要的作用。模型开发的持续进步进一步凸显了这个充满活力的领域的成长机会。

全球动物模型市场驱动因素

全球动物模型市场主要受基因组学和精准医学进展的驱动，这凸显了对能够真实反映个别患者特征及其对各种治疗反应的动物模型的需求。研究人员和製药公司越来越依赖这些模型来研究特定的基因突变并开发标靶治疗方法。患者来源的异种移植（PDX）模型的出现已成为该领域的关键方法，该模型将患者的肿瘤样本移植到动物体内进行药物测试。这些模型能够评估针对每位患者量身定制的治疗效果，推动了个人化医疗领域对动物模型的需求。

限制全球动物模型市场的因素

儘管动物模型领域取得了显着进展，但伦理问题和动物福利问题仍然是重大挑战。动物实验引发了重要的伦理争议，并激起了关于动物人道待遇的辩论。公众日益增长的关注以及严格的动物福利法规，使得动物模型的使用受到更多检验，尤其是在那些已製定完善动物福利立法的地区。这些伦理考量和法规结构阻碍了动物模型市场的发展，并迫切需要开发既能保持科学严谨性又能取代传统方法的替代技术和模型。

全球动物模型市场趋势

全球动物模型市场正经历着向人源化和转化模型的显着转变，这主要受人们对更贴近人类生理和疾病机制的需求所驱动。研究人员致力于开发整合人类细胞、组织和基因修饰的动物模型，以更精确地模拟人类病理。这种转变在人源化小鼠的开发中尤其明显，使得免疫介导疾病的研究和先进免疫疗法的测试更有效率。随着这一趋势的持续发展，它反映了更广泛的目标，即提高动物模型在药物研发和疾病研究中的可预测性和适用性，最终实现更有效的治疗方法。

查尔斯河实验室（美国）
杰克森实验室（美国）
Janvier Labs（法国）
Genoway（法国）
Ozgene（澳洲）
Hera Biolabs（英国）
Crown Bioscience（美国）
Inotiv（美国）
基因改造（日本）
JSR生命科学（日本）
百奥赛汀（中国）
哈伯生物医学（中国）
赛业生物科技（中国）
Horizon Discovery（英国）
Cellectis（法国）
CRISPR Therapeutics（瑞士）
Editas Medicine（美国）
Intellia Therapeutics（美国）

结论与建议

简介目录

Product Code: SQMIG35A2418

Global Animal Model Market size was valued at USD 3.03 Billion in 2024 and is poised to grow from USD 3.28 Billion in 2025 to USD 6.11 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global animal model market serves as a vital resource for researchers, offering models that accurately replicate human physiology and pathology. Key drivers for market expansion include the rising incidence of chronic diseases such as cancer, cardiovascular issues, and neurological disorders. Notably, advancements in genetically modified animals, like transgenic mice, are enabling in-depth exploration of specific genes and their association with disease progression. Furthermore, the growing emphasis on personalized medicine creates demand for patient-derived animal models that enhance tailored therapeutic approaches. Despite challenges like ethical dilemmas and emerging alternatives, the animal model market remains instrumental in disease understanding and drug innovation. Continuous advancements in model development further underscore opportunities for growth within this dynamic sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Model market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Model Market Segments Analysis

Global Animal Model Market is segmented by Animal Type, Technology, Application, End User and region. Based on Animal Type, the market is segmented into Mice, Rat, Guinea Pigs, Rabbits, Hamsters and Others. Based on Technology, the market is segmented into CRISPR, Microinjection and Embryonic Stem Cell Injection. Based on Application, the market is segmented into Research and Development, Production and Quality Control. Based on End User, the market is segmented into Research Institutes, Educational Institutes, Pharmaceutical Companies and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Model Market

The global animal model market is significantly driven by advancements in genomics and precision medicine, highlighting the necessity for animal models that closely reflect individual patient characteristics and their responses to various treatments. Researchers and pharmaceutical companies are increasingly relying on these models to investigate specific genetic variations and to create targeted therapeutic approaches. The emergence of patient-derived xenograft (PDX) models, which involve implanting patient tumor samples into animals for drug testing, has become a prominent avenue in this field. These models enable the evaluation of treatment efficacy tailored to individual patients, thereby propelling the demand for animal models in the realm of personalized medicine.

Restraints in the Global Animal Model Market

Despite notable progress in the field of animal models, ethical concerns and animal welfare issues continue to pose significant challenges. The employment of animals in research raises critical ethical questions and ignites discussions surrounding their humane treatment. Increasing public scrutiny, coupled with stringent animal welfare regulations, has intensified the examination of animal model usage, particularly in regions with robust welfare legislation. These ethical considerations and regulatory frameworks hinder the growth of the animal model market and spur the urgent need for alternative technologies and models that can replace traditional practices while maintaining scientific integrity.

Market Trends of the Global Animal Model Market

The Global Animal Model market is witnessing a notable trend toward humanized and translational models, driven by the demand for greater relevance to human physiology and disease mechanisms. Researchers are increasingly focusing on creating animal models that incorporate human cells, tissues, and genetic modifications to enhance their accuracy in mimicking human conditions. This shift is particularly evident in the development of humanized mice, which allows for more effective studies of immune-related diseases and the testing of advanced immunotherapies. As this trend continues, it reflects the broader goal of improving the predictability and applicability of animal models in drug development and disease research, ultimately leading to more effective therapeutic solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Animal Model Market Size by Animal Type & CAGR (2026-2033)

Market Overview
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others

Global Animal Model Market Size by Technology & CAGR (2026-2033)

Market Overview
CRISPR
Microinjection
Embryonic Stem Cell Injection

Global Animal Model Market Size by Application & CAGR (2026-2033)

Market Overview
Research and Development
Production
Quality Control

Global Animal Model Market Size by End User & CAGR (2026-2033)

Market Overview
Research Institutes
Educational Institutes
Pharmaceutical Companies
Contract Research Organizations

Global Animal Model Market Size & CAGR (2026-2033)

North America (Animal Type, Technology, Application, End User)
- US
- Canada
Europe (Animal Type, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Animal Type, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Animal Type, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Animal Type, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Charles River Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Jackson Laboratory (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Janvier Labs (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genoway (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ozgene (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hera Biolabs (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Crown Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inotiv (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transgenic (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JSR Life Sciences (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocytogen (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Harbour BioMed (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyagen Biosciences (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horizon Discovery (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellectis (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CRISPR Therapeutics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Editas Medicine (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intellia Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments